Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8913845rdf:typepubmed:Citationlld:pubmed
pubmed-article:8913845lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:8913845lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:8913845lifeskim:mentionsumls-concept:C0066614lld:lifeskim
pubmed-article:8913845lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:8913845pubmed:issue2lld:pubmed
pubmed-article:8913845pubmed:dateCreated1997-2-24lld:pubmed
pubmed-article:8913845pubmed:abstractTextThis study investigated the antitumoral activity in colorectal cancer and toxicity of a 5-day continuous infusion of a new cytostatic agent, Mitonafide, that had previously shown to be neurotoxic when administered as a short daily x 5 days infusion.lld:pubmed
pubmed-article:8913845pubmed:languageenglld:pubmed
pubmed-article:8913845pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8913845pubmed:citationSubsetIMlld:pubmed
pubmed-article:8913845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8913845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8913845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8913845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8913845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8913845pubmed:statusMEDLINElld:pubmed
pubmed-article:8913845pubmed:issn0167-6997lld:pubmed
pubmed-article:8913845pubmed:authorpubmed-author:MartínMMlld:pubmed
pubmed-article:8913845pubmed:authorpubmed-author:FongLLlld:pubmed
pubmed-article:8913845pubmed:authorpubmed-author:AbadAAlld:pubmed
pubmed-article:8913845pubmed:authorpubmed-author:MolinaFFlld:pubmed
pubmed-article:8913845pubmed:authorpubmed-author:BenavidesAAlld:pubmed
pubmed-article:8913845pubmed:authorpubmed-author:FabregatXXlld:pubmed
pubmed-article:8913845pubmed:authorpubmed-author:Díaz-PuenteM...lld:pubmed
pubmed-article:8913845pubmed:authorpubmed-author:GrávalosCClld:pubmed
pubmed-article:8913845pubmed:issnTypePrintlld:pubmed
pubmed-article:8913845pubmed:volume14lld:pubmed
pubmed-article:8913845pubmed:ownerNLMlld:pubmed
pubmed-article:8913845pubmed:authorsCompleteYlld:pubmed
pubmed-article:8913845pubmed:pagination223-5lld:pubmed
pubmed-article:8913845pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:meshHeadingpubmed-meshheading:8913845-...lld:pubmed
pubmed-article:8913845pubmed:year1996lld:pubmed
pubmed-article:8913845pubmed:articleTitlePhase II study of Mitonafide in advanced and relapsed colorectal cancer.lld:pubmed
pubmed-article:8913845pubmed:affiliationHospital Universitari Germans Trias i Pujol, Badalona, Spain.lld:pubmed
pubmed-article:8913845pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8913845pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8913845pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed